Novakand Pharma AB (publ) (LARK) — Net Asset Quality Index
Novakand Pharma AB (publ) (LARK) has a Net Asset Quality Index of 97.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr56.73 Million minus total liabilities of Skr1.24 Million yields net assets of Skr55.49 Million. A higher index indicates a stronger, lower-leverage balance sheet. See LARK defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Novakand Pharma AB (publ) Net Asset Quality Index Over Time (2012–2025)
This chart shows how Novakand Pharma AB (publ)'s Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of December 2025, the index stands at 97.8%, representing net assets of Skr55.49 Million against total assets of Skr56.73 Million SEK. Explore Novakand Pharma AB (publ) operating cash flow efficiency to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Novakand Pharma AB (publ) (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Novakand Pharma AB (publ) from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of Novakand Pharma AB (publ).
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.8% | Skr55.49 Million | Skr56.73 Million | Skr1.24 Million | ▲ +3.5 pp |
| 2024 | 94.3% | Skr71.58 Million | Skr75.88 Million | Skr4.30 Million | ▼ -2.2 pp |
| 2023 | 96.6% | Skr116.46 Million | Skr120.61 Million | Skr4.16 Million | ▲ +0.4 pp |
| 2022 | 96.1% | Skr152.12 Million | Skr158.22 Million | Skr6.10 Million | ▲ +0.9 pp |
| 2021 | 95.2% | Skr158.28 Million | Skr166.22 Million | Skr7.94 Million | ▲ +5.3 pp |
| 2020 | 90.0% | Skr71.43 Million | Skr79.41 Million | Skr7.98 Million | ▲ +43.6 pp |
| 2019 | 46.3% | Skr20.30 Million | Skr43.82 Million | Skr23.51 Million | ▼ -11.9 pp |
| 2018 | 58.3% | Skr20.46 Million | Skr35.12 Million | Skr14.66 Million | ▼ -21.8 pp |
| 2017 | 80.0% | Skr6.51 Million | Skr8.14 Million | Skr1.63 Million | ▼ -3.4 pp |
| 2016 | 83.4% | Skr4.08 Million | Skr4.89 Million | Skr809.66K | ▼ -10.2 pp |
| 2015 | 93.7% | Skr10.27 Million | Skr10.96 Million | Skr691.73K | ▲ +3.0 pp |
| 2014 | 90.7% | Skr5.67 Million | Skr6.25 Million | Skr582.04K | ▼ -2.9 pp |
| 2013 | 93.6% | Skr598.60K | Skr639.58K | Skr40.98K | ▲ +43.5 pp |
| 2012 | 50.1% | Skr298.09K | Skr594.67K | Skr296.58K | — |